Category News

Production of new astrocytes contributes to an improvement in depressive and anxious behavior

The production of new astrocytes in the adult human brain may contribute to an improvement in depressive and anxious behavior in patients with neuropsychiatric diseases, as well as to the restitution of neural cells in the hippocampus, a brain region important for the control of emotional and cognitive behaviors. These are the main conclusions of a study carried out by a research team from the ICVS, and recently published in the journal Molecular Psychiatry.

Read MoreProduction of new astrocytes contributes to an improvement in depressive and anxious behavior

ICVS Retreat 2024

More than 170 participants attended the ICVS Retreat 2024 at the Monastery of Tibães in Braga, between the 4th and 5th of July.  The program included presentations, debates, poster sessions, well-being and team building activities.

Read MoreICVS Retreat 2024

Study confirms the impact of aspergillosis on the prognosis of critically ill patients with viral pneumonia

Researchers from ICVS published a study in the American Journal of Respiratory and Critical Care Medicine, which assesses the influence of the lung microbiota on the incidence and clinical course of patients diagnosed with influenza-associated aspergillosis (IAPA) or COVID-19 (CAPA), or bacterial superinfections.

Read MoreStudy confirms the impact of aspergillosis on the prognosis of critically ill patients with viral pneumonia

ICVS researchers show that “40% of patients with Alzheimer’s disease suffer from psychosis and identifies affected areas of the brain”

A team of researchers from ICVS recently published an article in the journal “Neurobiology of Aging” that addresses how the presence of psychosis indicates a more negative prognosis and greater cognitive decline in patients diagnosed with the disease of Alzheimer's.

Read MoreICVS researchers show that “40% of patients with Alzheimer’s disease suffer from psychosis and identifies affected areas of the brain”

ICVS collaborates in first study on the prevalence of asthma in Portugal: more than 570 thousand people have the disease

More than 570,000 adults live with asthma in Portugal, a disease that has a prevalence of 7.1%. Of these thousands of people, almost seven in 10 (68%) do not have their disease under control, show data from “EPI-ASTHMA - Prevalence and characterization of people with asthma, according to the severity of the disease, in Portugal”, a study developed in collaboration by ICVS, CINTESIS of the University of Porto and AstraZeneca Portugal.

Read MoreICVS collaborates in first study on the prevalence of asthma in Portugal: more than 570 thousand people have the disease